Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.
about
Hepatitis B vaccination for reducing morbidity and mortality in persons with HIV infectionInsights on common vaccinations in HIV-infection: efficacy and safetyVaccination in patients with primary immune deficiency, secondary immune deficiency and autoimmunity with immune regulatory abnormalitiesHepatitis B and A vaccination in HIV-infected adults: A reviewHepatitis B and human immunodeficiency virus co-infectionIntradermal vaccination using the novel microneedle device MicronJet600: Past, present, and futureAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.Lower Baseline Germinal Center Activity and Preserved Th1 Immunity Are Associated With Hepatitis B Vaccine Response in Treated HIV Infection.Vaccination in HIV-infected adults.Hepatitis B vaccine by intradermal route in non responder patients: an update.Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-12013 IDSA clinical practice guideline for vaccination of the immunocompromised host.Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review.Effectiveness of HBV vaccination in infants and prediction of HBV prevalence trend under new vaccination plan: findings of a large-scale investigation.Comparison of immunogenicity and safety of four doses and four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: a randomized, controlled trial.Postexposure prophylactic effect of hepatitis B virus (HBV)-active antiretroviral therapy against HBV infection.Rapid loss of vaccine-acquired hepatitis B surface antibody after three doses of hepatitis B vaccination in HIV-infected persons.Influenza vaccine response profiles are affected by vaccine preparation and preexisting immunity, but not HIV infection.No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected Adults.Immune response to hepatitis B virus vaccination among HIV-1 infected and uninfected adults in Kenya.Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.Response to hepatitis B vaccination among HIV-infected adults in Vietnam.Antiretroviral Therapy as Prevention of … Pneumococcal Infections?Prevention of Sexually Transmitted Diseases in HIV-Infected Individuals.Vaccination against viral hepatitis of HIV-1 infected patients.Does increased hepatitis B vaccination dose lead to a better immune response in HIV-infected patients than standard dose vaccination: a meta-analysis?Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis.New approaches in hepatitis B vaccination for celiac disease.Old and new adjuvants for hepatitis B vaccines.Prevention of hepatitis B virus infection: from the past to the future.Emerging challenges in managing hepatitis B in HIV patients.Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I.Hepatitis B virus vaccination in HIV-infected people: A review.Vaccination Against Hepatitis B Virus (HBV) in HIV-1-Infected Patients With Isolated Anti-HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Study.Hepatitis B infection acquired after haematopioetic stem cell transplant through horizontal mode.Achieving protection against HBV in HIV patients: Finding the best strategy.[Vaccination against hepatitis B: success and challenges].British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015.Immunization of HIV-infected adult patients - French recommendations.
P2860
Q24193121-C7376772-7619-4A3D-B63D-A1F76E6E4F5EQ26770665-9383072C-2588-47F4-B1E7-FA6404D1CF63Q26796420-ED38D6C1-A91E-46CF-A1A8-6BA29BE90FF2Q26799782-8E16AF33-4E34-42D2-A8AD-F326829F0CF0Q26822862-5D03667E-FEE3-4F06-A349-2C5B219E235FQ28087074-BD48C86C-E30D-4925-8A1B-9345D1A4FAFCQ30391932-C33F8C91-5197-4675-9D6B-27E3A9D456DEQ30412422-D3A8DF75-72B2-487D-87E4-68625AF0A41DQ33745613-2E2C1485-FE9D-4E09-BA3B-3B974157F073Q33980764-F5D7CA1F-D4EB-401E-B2F7-2012259E70D1Q34036643-684BC6D3-376F-4CEB-B09C-701E414F751EQ34077801-F93E1B32-F750-4AB2-A86B-55E62DA09429Q34390072-F9DDB8DC-1B49-4B95-B49F-44672A9A27D3Q34405008-A52DE00C-9347-4BF2-9B35-4DFE3F46AD6AQ34456589-72C3D968-33AD-4DB1-BF65-F590F74A0FA3Q35050640-96376AB1-B800-4BB0-8A43-30BDB34BA3C7Q35105851-665156ED-5599-4235-9EF9-0926A340141FQ35641943-71A5E4E9-4700-4BB3-BD85-125927C6B89FQ35887739-14FDD91A-C4A4-416D-AF09-BB29EB440959Q36225293-B690347C-B8FA-41AE-B8B1-EFA139A10F86Q36509801-35B65414-B32F-40E2-945B-191436520E1AQ36799939-08462C40-DA81-4266-BA7A-00012231BE6DQ37136221-CD918185-EB35-4F44-B6EB-B96BF37DB158Q37518007-9F22E9EC-A0B4-4604-B051-76F93CD5652AQ37834503-7C4CC920-408A-438A-BAD9-CC501CBC3F41Q38013507-8FA09B17-BD43-48F5-B084-A773EBDBA246Q38087214-78E0835A-77C5-4AD4-A940-CA54C963FB81Q38177767-03DB58A1-7ECC-4D79-A1A3-A15CC457B176Q38260053-B54382C1-E15D-4CD9-B18A-879D025D65F2Q38293586-A5FAA6D3-232A-472D-BDB7-591E5AF1E00AQ38354222-43D59C0A-26E7-4913-BCAE-2A42CB3EADE2Q38544189-8F966603-595E-432C-A417-C651D2C0FA47Q38639401-A9AD1638-85BD-4325-98F1-381CFA400B72Q39166033-2F9B348F-F87B-448C-A4BE-29BF20156265Q40107327-47285ACA-8553-4E36-A868-6CF852085789Q40231103-818A9D3F-B6A3-4069-B688-9ECA7AF9CD19Q40527467-3110DE28-A3BA-44A3-AB1D-258DBECF5268Q40544414-C88F2E2F-83B1-4EBB-A8CF-222AF89F65C0Q40560650-60A80F8D-2AB3-4104-87B8-9699ED86F1F3Q40615516-EF396130-F1EB-4D95-AC84-28321CEDEEBB
P2860
Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Safety and immunogenicity of 4 ...... a randomized controlled trial.
@en
type
label
Safety and immunogenicity of 4 ...... a randomized controlled trial.
@en
prefLabel
Safety and immunogenicity of 4 ...... a randomized controlled trial.
@en
P2093
P50
P356
P1476
Safety and immunogenicity of 4 ...... a randomized controlled trial.
@en
P2093
ANRS HB03 VIHVAC-B Trial
Arielle R Rosenberg
Diane van der Vliet
Karine Martin
Laurence Slama
Lionel Piroth
Marie-Louise Michel
Nathalie Colin de Verdière
P304
P356
10.1001/JAMA.2011.351
P407
P577
2011-04-01T00:00:00Z